↓ Skip to main content
What is this page? Embed badge

Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC

Overview of attention for article published in Journal of Thoracic Oncology, January 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
1 policy source
twitter
12 X users
reddit
1 Redditor

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
99 Mendeley
Summary Policy documents X Reddit Dimensions citations

This page is provided by Altmetric.